Drug Shortage Report for NAT-ESCITALOPRAM
Report ID | 218258 |
Drug Identification Number | 02440318 |
Brand name | NAT-ESCITALOPRAM |
Common or Proper name | ESCITALOPRAM |
Company Name | NATCO PHARMA (CANADA) INC |
Market Status | MARKETED |
Active Ingredient(s) | ESCITALOPRAM |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2024-02-02 |
Estimated end date | 2024-05-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5N 1P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-04-08 | French | Compare |
v5 | 2024-04-08 | English | Compare |
v4 | 2024-02-03 | English | Compare |
v3 | 2024-02-02 | French | Compare |
v2 | 2024-02-02 | English | Compare |
v1 | 2024-02-02 | English | Compare |
Showing 1 to 6 of 6